Alopecia Treatment Market by Drug Type
The global alopecia treatment market was valued at $2,736 million in 2018, and is projected to reach $3,935 million by 2026, registering a CAGR of 4.6% from 2019 to 2026.
Alopecia is a term used to describe extreme hair loss or hair damage under certain dietary issues and medical conditions. It is a common autoimmune disease, which causes bald spots resulting in partial or complete hair loss. It can affect persons of all gender and at any stage of life, it commonly affects mid-aged generation.
Various hair transplant therapies and drugs can be used for the treatment of alopecia condition. Treatment of alopecia condition can be carried out using drugs such as minoxidil, finasteride, and other drugs.
Significant increase in the prevalence of chronic diseases such as hypertension, arthritis, Polycystic Ovary Syndrome (PCOS), and depression; rise in geriatric population; hormonal imbalance; high level of stress; increase in consumption of alcohol & tobacco, change in food habits, and increase in the prevalence of chemotherapy-induced alopecia fuel the growth of the alopecia treatment market.
Moreover, rise in awareness programs for alopecia treatment & management; increase in the prevalence of alopecia conditions such as androgenic alopecia, alopecia areata, alopecia totalis and others; and genetic factors might contribute toward the rise in incidences of alopecia among both men & women are other factors that contribute toward the growth of the market. However, poor demand for alopecia treatment drugs in underdeveloped countries are expected to hinder the growth of the market.
The alopecia treatment market is segmented into drug type, indication, distribution channel, and region. By drug type, the market is categorized into minoxidil, finasteride, and other drug types. The indication covered in the study include androgenic alopecia, alopecia areata, alopecia totalis and others.
Depending on distribution channel, the market is classified into hospitals pharmacies, drug stores & retail pharmacies, and online pharmacies. On the basis of region, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).
KEY BENEFITS FOR STAKEHOLDERS
– The study provides an in-depth analysis of the market along with the current trends and future estimations to elucidate the imminent investment pockets.
– It offers a quantitative analysis from 2018 to 2026, which is expected to enable the stakeholders to capitalize on the prevailing market opportunities.
– A comprehensive analysis of all the geographical regions is provided to determine the existing opportunities.
– The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook of the global market.
KEY MARKET SEGMENTS
By Drug Type
– Other Drug Types
– Androgenic Alopecia
– Alopecia Areata
– Alopecia Totalis
By End User
– Hospitals Pharmacies
– Drug Stores & Retail Pharmacies
– Online Pharmacies
– North America
o Rest of Europe
o South Korea
o Rest of Asia-Pacific
o Saudi Arabia
o South Africa
o Rest of LAMEA
LIST OF KEY PLAYERS PROFILED IN THE REPORT
– Capillus, LLC
– Cipla Inc.
– Daiichi Sankyo Company, Limited
– GlaxoSmithKline Plc
– Johnson & Johnson
– Merck & Co., Inc.
– Sun Pharmaceutical Industries Ltd.
– Transitions Hair
– Vitabiotics Ltd.
– Vita-Cos-Med Klett-Loch GmbH
LIST OF OTHER PLAYERS IN THE VALUE CHAIN (These players are not profiled in the report. The same will be included on request.)
– Dr. Reddy’s Laboratories
– Concert Pharmaceuticals Inc.
– Aclaris Therapeutics, Inc.
Alopecia Treatment Market by Drug Type
- Global Stem Cell Alopecia Treatment Market Research Report 2019-2026
- Hair Transplant Market
- New OTC Dual Action System Launched for Hair Loss
- InventHelp Inventor Develops Hair-Care Formulas
- JAK inhibitor promotes hair growth
- Trained Nurse and BOOST n BLEND® Hair Loss Expert Bambi Staveley Discusses Post Pregnancy Hair Loss, and What Can be Done About it